---
figid: PMC11880705__gr3
figtitle: 'NS1 in counteracting innate immunity1: Binding of NS1 to p85Beta-SH2 relieved
  p85B repression of p110a, activated PI3/Akt signaling, and inhibited the apoptotic
  program induced by influenza virus'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11880705
filename: gr3.jpg
figlink: /pmc/articles/PMC11880705/figure/F3/
number: F3
caption: 'Role of NS1 in counteracting innate immunity1: Binding of NS1 to p85β-SH2
  relieved p85β repression of p110a, activated PI3/Akt signaling, and inhibited the
  apoptotic program induced by influenza virus. 2: IAV NS1 decreases RIG-I activation,
  and therefore, IFN responses, through the sequestration of dsRNA (represented with
  two parallel lines), or by interaction with RIG-I, TRIM25 or Riplet, resulting in
  the suppressed ubiquitination and activation of RIG-I. 3: NS1 can directly bind
  PKR, inhibit the activation of PKR, prevent the phosphorylation of eIF2a by PKR,
  and promote the synthesis of viral proteins. 4: NS1 competitively binds dsRNA with
  OAS and inhibits OAS/RNase L signaling pathway activation. 5: NS1 impairs NLRP3
  inflammasome activation as well as decreases the cleavage of pro-interleukin (IL)-1b
  and pro-IL-18 into their mature forms. 6 and 7: IAV NS1 inhibits the activation
  of transcription factors such as IRF3, NF-κB, impairing type I IFN production, and,
  therefore, the induction of ISGs. 8 and 9: NS1 proteins can bind to CPSF30. In addition,
  IAV NS1 binds to PABPII. These interactions of IAV NS1 with CPSF30 and PABPII block
  the cleavage of immature mRNAs (pre-mRNAs) and the recruitment of the poly(A) polymerase
  to add the poly(A) tail and function of PABPII to stimulate the synthesis of long
  poly(A) tails, respectively, leading to host protein shutoff. dsRNA, double-stranded
  RNA; RIG-I, retinoic acid-inducible gene I; TRIM25, tripartite motif containing
  25; IRF3, interferon regulatory factor 3; NF-κB, nuclear factor kappa beta; PKR,
  protein kinase R; OAS, 2′,5′-oligoadenylate synthetase; NLRP3, NLR family pyrin
  domain containing 3; CPSF30, cleavage and polyadenylation specificity factor 30;
  PABPII, poly(A)-binding protein II'
papertitle: The applications of live attenuated influenza a virus with modified NS1
  gene
reftext: Hongbo Zhang, et al. Mol Ther Nucleic Acids. 2025 Mar 11;36(1).
year: '2025'
doi: 10.1016/j.omtn.2025.102471
journal_title: Molecular Therapy. Nucleic Acids
journal_nlm_ta: Mol Ther Nucleic Acids
publisher_name: American Society of Gene & Cell Therapy
keywords: 'MT: Delivery Strategies | influenza | live attenuated influenza vaccine
  | NS gene'
automl_pathway: 0.9576046
figid_alias: PMC11880705__F3
figtype: Figure
redirect_from: /figures/PMC11880705__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11880705__gr3.html
  '@type': Dataset
  description: 'Role of NS1 in counteracting innate immunity1: Binding of NS1 to p85β-SH2
    relieved p85β repression of p110a, activated PI3/Akt signaling, and inhibited
    the apoptotic program induced by influenza virus. 2: IAV NS1 decreases RIG-I activation,
    and therefore, IFN responses, through the sequestration of dsRNA (represented
    with two parallel lines), or by interaction with RIG-I, TRIM25 or Riplet, resulting
    in the suppressed ubiquitination and activation of RIG-I. 3: NS1 can directly
    bind PKR, inhibit the activation of PKR, prevent the phosphorylation of eIF2a
    by PKR, and promote the synthesis of viral proteins. 4: NS1 competitively binds
    dsRNA with OAS and inhibits OAS/RNase L signaling pathway activation. 5: NS1 impairs
    NLRP3 inflammasome activation as well as decreases the cleavage of pro-interleukin
    (IL)-1b and pro-IL-18 into their mature forms. 6 and 7: IAV NS1 inhibits the activation
    of transcription factors such as IRF3, NF-κB, impairing type I IFN production,
    and, therefore, the induction of ISGs. 8 and 9: NS1 proteins can bind to CPSF30.
    In addition, IAV NS1 binds to PABPII. These interactions of IAV NS1 with CPSF30
    and PABPII block the cleavage of immature mRNAs (pre-mRNAs) and the recruitment
    of the poly(A) polymerase to add the poly(A) tail and function of PABPII to stimulate
    the synthesis of long poly(A) tails, respectively, leading to host protein shutoff.
    dsRNA, double-stranded RNA; RIG-I, retinoic acid-inducible gene I; TRIM25, tripartite
    motif containing 25; IRF3, interferon regulatory factor 3; NF-κB, nuclear factor
    kappa beta; PKR, protein kinase R; OAS, 2′,5′-oligoadenylate synthetase; NLRP3,
    NLR family pyrin domain containing 3; CPSF30, cleavage and polyadenylation specificity
    factor 30; PABPII, poly(A)-binding protein II'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EIF2AK2
  - TRIM25
  - RNF135
  - PTPN11
  - IVNS1ABP
  - OAS1
  - RIGI
  - RNASEL
  - PIK3CA
  - IRF3
  - NFKB1
  - IFNK
  - IFNW1
  - IFNA1
  - IFNA2
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA17
  - IFNA21
  - IFNB1
  - AKT1
  - AKT2
  - AKT3
  - GSK3A
  - GSK3B
  - CPSF4
  - NS1
  - Pre-mRNA
---
